The relative safety of homologous blood transfusion is in large part due to constant surveillance by blood bankers and clinicians. Quality control of blood supply and transfusion includes collection, documentation, storage, serological testing, administration and follow-up. The provision of serologically compatible blood requires meticulous monitoring of grouping, screening and crossmatching techniques. A hospital transfusion committee should be an integral part of any quality control programme to ensure effective communication between clinical, laboratory and administrative staff.
A transfusion reaction has been previously defined as "any unfavourable systemic effect following directly upon the transfusion of donor blood (or blood components) into a recipient". 1 Within this wide-ranging definition there may be transfusion reactions which are rapid in onset, overt, dramatic and potentially fatal, while others may be unsuspected, subtle and delayed by days, weeks or even months.
There is an element of paradox implicit in the title of this paper, in that quality control might be expected to be incompatible with a transfusion reaction, or conversely, that a transfusion reaction represents a failure of quality control. Since those involved in handling blood at every level are only human, errors will occur from time to time, in spite of carefully applied quality control procedures.
It is important for all those involved in any aspect of transfusion practice to be aware of the potential hazards of blood transfusion and to minimise the likelihood of their occurrence by stringently applied principles of quality control.
CLASSIFICATION OF TRANSFUSION REACTIONS
A classification of transfusion reactions emphasising administrative aspects of blood transfusion practice is set out in Table 1 . A clinical classification, divided essentially on a temporal basis, is shown in Table 2 . 
Clinical forms of transfusion reaction A. EARLY
Other papers in this symposium will deal with several of these topics, and they are noted here for the sake of completeness only. Such causes of complications of transfusion as air embolism and thrombophlebitis have become far less common with the almost universal use of disposable plastic blood packs and intravenous cannulae. This paper will examine principally the non-immune causes of transfusion reaction and the means of preventing them, and will then examine the ways in which red cell based incompatibilities can be minimised by application of quality control principles.
NON-IMMUNE TRANSFUSION REACTIONS AND THEIR PREVENTION

Documentation
While clinical and pathophysiological complications can and do occur following blood transfusion, and although bench-based errors are at times responsible for these mistakes, it is recorded fact that more errors in practice occur as a result of clerical error, inaccuracy or inadequate checking procedures.
Sample confusion can occur in the ward and in the casualty department, particularly if the collection is carried out under stress. To avoid this error, it is necessary to draw one sample at a time into tubes which are not pre-Iabelled. When sample collection is being done in a stressful situation, extra care is required. Samples may also be confused at the laboratory bench.
Specimen labelling should be done at the time of the collection, not after the event, nor in anticipation of it. Incorrect, imprecise and incomplete specimen labelling is a continuing hazard of transfusion practice, often aggravated by the paucity of space available for precise details on the specimen tube label. This error can be prevented by care and accuracy. At times, the laboratory is certainly justified in refusing to accept inappropriately labelled or inadequately identified specimens.
Request forms incorrectly or inadequately completed represent an entirely preventable source of error in transfusion practice. It is difficult to convince some clinicians that precise patient information, in as much detail as is sought, is of great importance to the crossmatching laboratory, particularly when it concerns previous transfusion episodes or pregnancy or both. The incidence of Anaesthesia and Intensive Care. Vol. VllI, No. 2, May, 1980 isosensitization following transfusion is between 1 and 2070 and as similar levels apply for pregnancy2 this information may well be critical. Possible difficulties in obtaining blood may be anticipated or overcome more quickly when this kind of information is available, and the time saved may well be life-saving for the patient.
STORAGE
Blood for transfusion is a living tissue transplant, and demands more care and respect in its handling than to be put in the ward refrigerator with the nursing staff supper, or worse, in the hospital's cool room with the week's vegetable supply. Responsibility for supervision of the storage of blood should be clearly defined in both large and small hospitals.
The temperature at which blood is stored is critical; if the temperature falls below the specified range of 4-6°C, lysis of red cells may occur, while a rise above the range may encourage the growth of any bacteria present. The end result of incorrect storage of blood may be inconsequential, but if the breach of storage conditions has been long-lasting or of some magnitude, the effect on the patient may be severe. All refrigerators in which blood is stored should have alarms fitted to them, both local and remote, and temperature-recording charts which are changed regularly by observant staff who are alert to possible serious changes before the consequences are irreversible. Although there are no legal requirements governing the specification of blood bank refrigerators, guidelines concerning the handling of blood and its refrigeration have been set out by the Australian Red Cross Society's National Blood Transfusion Committee, and copies of these are readily obtainable from the major blood centres in each capital city. It is essential that refrigerators in which blood and blood products are stored should conform to the set standards; adequate storage at the blood collection centre and major laboratories may be nullified completely if the crossmatched blood is sent to a ward or operating theatre and held in an ordinary domestic refrigerator without appropriate temperature control. It is also important to remember that great care must be taken with blood and blood components in transit to ensure the most satisfactory conditions of storage.
The Lesion of Storage and its Correction
Massive transfusion brings with it a series of potential non-immunological problems related to the fact that the blood transfused into the patient has the biochemical and physiochemical characteristics of stored bank blood. Stored blood is at 4°C and contains an excess of the citrate used for anticoagulation and the potassium which has leaked from the red cells into plasma during storage. Platelets and the labile clotting factors are reduced to insignificant levels after 24-48 hours of storage. Hypothermia induced by stored blood is not beneficial to the patient,3 citrate toxicity is a risk in patients with diseased livers unable to metabolise this salt, a sudden influx of free potassium may be more than a patient with renal failure can handle, while the lack of platelets and labile clotting factors may hinder haemostasis in a bleeding patient. Minimising the predictable effects of transfusion of stored blood is an important facet of quality control in blood transfusion practice. Today, most blood used in operating theatres is warmed to 37°C in thermostatically controlled water baths as the blood is infused. Citrate toxicity is a problem chiefly encountered with the aged patient and with the neonate. In many exchange transfusions, calcium, as either the gluconate or chloride, may be given to neutralise the effect of the citrate. The effects of storage on the constituents of blood are usually short lived, for a matter of hours only. The high free potassium level is quickly corrected after infusion, and the potassium bolus remains a problem mainly for the patient with chronic renal disease and the premature neonate. Although the platelet count in massive transfusion may fall below lOO,OOO/cu. mm., patience is the treatment of choice unless it is considered that thrombocytopenia is contributing to continuing bleeding, when platelets may be indicated. Although the clotting factor level will return quickly once bleeding has ceased, it is current practice in a number of centres to use fresh frozen plasma routinely when two litres or more of stored blood are given, on the basis of one unit of fresh frozen plasma per litre of blood after the first litre.
ADMlNlSTRA T10N
The responsibility for issuing crossmatched blood for transfusion should rest with a senior member of staff, and the correctness of issue and accurate recording of data should be checked by a second person. Whenever a transfusion is commenced or blood packs changed, a responsible medical officer (or his delegate) should always check that the name on both packs agrees with the precise, objective identification of the recipient. The blood group shown on the pack, the dates of collection and expiry, and the compatibility label should also be checked and then these checks should be confirmed by a second person whenever possible. In this matter, special care must be taken when the recipient is unconscious.
INFECTIOUS DISEASE
Infection may be a short or long-term sequel of transfusion. Bacterially contaminated blood may provoke an acute haemolytic reaction, although this risk has been virtually eliminated with the use of disposable plastic packs. Malaria and brucellosis are two well recognised transfusion-related infections, and exclusion of donors who are potential carriers must be made on the basis of the donor history, as there is no appropriately simple screening test available. The current Australian Red Cross Blood Transfusion Service policy is to exclude from whole blood donation any person who has been in a known malarious area in the previous two years. It is a reflection of the mobility of the Australian population, and a logistic problem for the Blood Transfusion Service, that 8 to 9070 of donors come into this category.
The possibility of blood-borne syphilis, recognised for many years, is excluded by one of a number of screening tests, such as the VDRL, RPR or ART. A slight risk still exists with a donor in the early stages of treponemal infection who has not yet developed detectable serological evidence of infection, but this risk is minimised by routine refrigeration, where storage for 24 to 48 hours ensures that spirochaetes are no longer infective.
Hepatitis B is now routinely screened for in all blood banks, but there are two associated problems which have tempered the enthusiasm with which the screening techniques were greeted ten years ago. It is recognised that the most sensitive serological test presently available is not capable of detecting all carriers of hepatitis B surface antigen, since the infective dose is around 100 times less than the best detection level. It is also known that in half of the recognised cases of post-transfusion hepatitis, neither hepatitis A nor B can be implicated, and it is presumed that these infections are due to non-A non-B hepatitis virus (or viruses).
This serious complication of transfusion, while less common than it was a decade ago, has by no means been eliminated.
OTHER NON-IMMUNOLOGICAL TRANSFUSION REACTIONS -
Circulatory overload may be prevented by using red cell concentrates where possible, and by careful clinical observation of the recipient during transfusion.
The risks of air embolism and thrombophlebitis have been reduced significantly by the use of plastic containers and infusion cannulae.
PREVENTION OF RED CELL INDUCED TRANSFUSION REACTIONS
Selection of Compatible Blood
In most major centres, there is usually sufficient blood available for a patient to receive blood of his own ABO and Rh group. Some centres transfuse on the basis of the Kell group as well. There are nevertheless some situations where this desirable aim cannot be met. Patients undergoing emergency transfusion may initially receive group 0 blood (either D positive or D negative) if it is not possible to obtain group specific blood. 4 In some situations, for logistic reasons, group 0 has been used with safety in all recipients. The U.S. Armed Services in Vietnam 5 used 100,419 units of group 0 blood ("Universal Donor") with no reported deaths from incompatibility. On the other hand, there were 49 haemolytic transfusion reactions and 9 deaths following use of 457,069 units of group-specific fully crossmatched blood. The majority of complications of transfusion occurred as the result of one or more of the non-immunological reasons noted above. A similar programme has operated with success in a civilian context in a major New Zealand centre.
When large volumes of blood of a less common group have been used, the inability of the blood bank to continue to supply groupspecific blood makes it necessary at times to select compatible blood from another ABO and possibly another Rh group. For example, an AB Rh (D) negative patient may need to receive A Rh (D) negative blood, which is to be preferred to B Rh(D) negative blood because the anti-B present in the group A blood is less likely to cause problems than the anti-A present in group B blood. If group 0 blood is selected, it should be of low haemolysin titre, and if possible, should be administered as packed cells.
Control of Key Variables
Quality control of transfusion, and the minimising of transfusion reaction as a result, relies upon 3 variables -the staff, the techniques and the reagents used. 6 Staff selection and training are of considerable importance in minimising the potential laboratory error. Changes in education patterns have resulted in an influx of university graduates into hospital blood bank and transfusion service laboratories, replacing in large measure those who received on-the-job training and part-time formal instruction. The new laboratory worker is strong on booklearning and theory, and correspondingly weaker in acquired practical skills. These qualities need to be recognised when devising training programmes.
Techniques. The total number of test procedures and manipulations carried out in a blood transfusion laboratory or a blood product laboratory does not compare with those done in a clinical chemistry or industrial laboratory, but they all need to be recognised, documented and controlled carefully. This applies both to the blood samples collected from donors and recipients, and those relating to the processing, storage and issue of donor blood.
For each laboratory procedure undertaken, there should be a written protocol, regular and consistent use of controls, both positive and negative, and frequent review of procedures to ensure that the written protocols are being followed.
For blood products, in addition to the use of protocols and controls, it is important that there be regular assessment of the effectiveness of each product by both in vivo and in vitro methods wherever practicable. The application of accepted standards of handling donor material and the importance of sterility are of importance to both staff and recipients alike.
Reagents. The strength and limitations of each reagent used in blood transfusion laboratories must be recognised and subjected to regular scrutiny, especially when batches are changed. As a general rule, most of the commercially obtained serological reagents used in immunohaematology are satisfactory, because of regulations in their countries of origin and competitiveness in the market place. Many laboratories supplement the commercially available cell panels with private panels of local origin. An important factor in accuracy in this area is the routine confirmation by another laboratory of a locally harvested antibody destined for laboratory use, if only to ensure that a mixture has not been missed.
Crossmatching and Standardisation. It has been traditional for laboratories involved in crossmatching to perform a range of tests of compatibility, the underlying philosophy being that each test has specificities different from the others, and an inappropriate reaction may be detectable in one mode but not in another. More cynically, it sometimes would appear that three or more tests are performed in the hope that one may be working well enough to pick up any abnormality.
The saline crossmatch serves as a check on the ABO group of the donor and recipient, and will pick up occasional anomalies. On the evidence presented in the R.C.P.A. Quality Assurance Programmes over the past several years, it is surprising that this test is still performed at 4 QC, 22 QC and 37 QC by a number of laboratories.
The indirect antiglobulin test (Coombs test) is universally accepted as an essential feature of crossmatching, and there is general agreement concerning the methods used, although incubation times may vary by a factor of 2. The use of enzyme tests has increased markedly in recent years. While there are to be found advocates of each technique, the twostage papain is the technique most commonly used throughout Australia, although there are marked variations from one centre to another as to how the two-stage papain test is performed.
Albumin techniques are used in around half the laboratories which participate in the R.C.P.A. Quality Assurance Programme, although it would appear that there is no information provided by this particular method of crossmatching which will not be available from either the Coombs test, the enzyme test, or both.
Although crossmatching uniformity and standardisation would appear to offer some advantages, such nationwide acceptance appears unlikely. It is, however, of considerable interest to note that in most if not all states in recent years, there have been set up active interdisciplinary groups which are involved in monitoring, ralslllg and maintaining standards of crossmatching and in identifying, where possible, flaws m existing laboratory procedures.
Whatever procedure is used, it is the responsibility of the pathologist in charge of the laboratory, as well as the scientific officers, technical officers, and technical assistants who work at the laboratory bench, to know intimately all methods which are used in the immunohaematology laboratory, to have confidence in them, to know how and when such methods may vary from standard accepted procedures, and to know what the pitfalls are likely to be in each procedure.
Quality control of all aspects of blood transfusion practice from donor handling to the infusion of the appropriately crossmatched product will ensure that transfusion will remain a relatively safe procedure, which will achieve for the patient the aim of the therapy concerned.
DOCUMENTATION OF TRANSFUSION REACTION
No individual or laboratory likes to have to admit to an error. It is nevertheless important Anaesthesia and Intensive Care, Vol. VlI!, No. 2, May, 1980 that any transfusion reaction be documented in the patient's own clinical notes, and that any such reaction be reported promptly both to the blood bank which crossmatched the blood as well as to the transfusion service which collected the blood, should it be implicated. It is only in this way that any proper indication of the incidence of transfusion reaction can be acquired. It is fair to say that most Australian transfusion services have no accurate idea of the incidence of post-transfusion reaction, with the possible exception of major haemolytic transfusion reaction and post-transfusion hepatitis.
One procedure which merits support is that of criteria review within an individual hospital context, where a multi-disciplinary committee reviews the way in which blood and blood components are used. Included in such reviews Anaesthesia and Intensive Care. Vol. VlIf, No. 2, May, 1980 is the examination of any untoward reaction to transfusion. This internal form of quality control is an important one in which more hospitals should become involved.
